Nalmefene hydrochloride injection
Nalmefene Hydrochloride Injection is a prescription opioid antagonist used to reverse opioid overdoses. It comes in solution form for intramuscular, intravenous, or subcutaneous administration, with strengths like 0.1 mg/mL or 1 mg/mL. Manufactured by Chengdu Shuode Pharmaceutical Co., Ltd. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Nalmefene Hydrochloride Injection is a prescription opioid antagonist used to reverse opioid overdoses. It comes in solution form for intramuscular, intravenous, or subcutaneous administration, with strengths like 0.1 mg/mL or 1 mg/mL. Manufactured by Chengdu Shuode Pharmaceutical Co., Ltd. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Nalmefene hydrochloride injection",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Nalmefene hydrochloride injection — ANDA 216007 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216007"
}
]
|
| identifier | ANDA216007 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"medications",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Nalmefene hydrochloride injection |
